Mayne Pharma Group Limited (MYX.AX)

AUD 4.85

(-2.02%)

Total Assets Summary of Mayne Pharma Group Limited

Mayne Pharma Group Limited's latest annual total assets in 2024 was 1.14 Billion AUD , down -8.41% from previous year.
Mayne Pharma Group Limited's latest quarterly total assets in 2024 FY was 1.14 Billion AUD , down -8.4% from previous quarter.
Mayne Pharma Group Limited reported annual total assets of 1.24 Billion AUD in 2023, down -4.22% from previous year.
Mayne Pharma Group Limited reported annual total assets of 1.3 Billion AUD in 2022, down -11.84% from previous year.
Mayne Pharma Group Limited reported quarterly total assets of 1.14 Billion AUD for 2024 FY, down -8.4% from previous quarter.
Mayne Pharma Group Limited reported quarterly total assets of 1.14 Billion AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Mayne Pharma Group Limited (2024 - 2007)

Historical Annual Total Assets of Mayne Pharma Group Limited (2024 - 2007)

Year	Total Assets	Total Assets Growth
2024	1.14 Billion AUD	-8.41%
2023	1.24 Billion AUD	-4.22%
2022	1.3 Billion AUD	-11.84%
2021	1.47 Billion AUD	-19.76%
2020	1.84 Billion AUD	12.62%
2019	1.63 Billion AUD	-10.64%
2018	1.83 Billion AUD	-4.06%
2017	1.9 Billion AUD	25.05%
2016	1.52 Billion AUD	188.46%
2015	528.94 Million AUD	98.99%
2014	265.82 Million AUD	13.89%
2013	233.39 Million AUD	332.74%
2012	53.93 Million AUD	0.48%
2011	53.67 Million AUD	-24.56%
2010	71.14 Million AUD	785.41%
2009	8.03 Million AUD	-31.28%
2008	11.69 Million AUD	-24.61%
2007	15.51 Million AUD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	1.15 Billion AUD	0.0%
2024 FY	1.14 Billion AUD	-8.4%
2024 Q4	1.14 Billion AUD	0.0%
2023 FY	1.24 Billion AUD	-4.22%
2023 Q4	1.24 Billion AUD	0.0%
2023 Q2	1.49 Billion AUD	0.0%
2022 Q2	1.48 Billion AUD	0.0%
2022 Q4	1.3 Billion AUD	0.0%
2022 FY	1.3 Billion AUD	-11.84%
2021 Q2	1.5 Billion AUD	0.0%
2021 Q4	1.47 Billion AUD	0.0%
2021 FY	1.47 Billion AUD	-19.76%
2020 FY	1.84 Billion AUD	12.62%
2020 Q4	1.84 Billion AUD	0.0%
2020 Q2	1.88 Billion AUD	0.0%
2019 Q2	2.01 Billion AUD	0.0%
2019 FY	1.63 Billion AUD	-10.64%
2019 Q4	1.63 Billion AUD	0.0%
2018 Q2	1.72 Billion AUD	0.0%
2018 Q4	1.83 Billion AUD	0.0%
2018 FY	1.83 Billion AUD	-4.06%
2017 Q2	1.94 Billion AUD	0.0%
2017 FY	1.9 Billion AUD	25.05%
2017 Q4	1.9 Billion AUD	0.0%
2016 Q4	1.52 Billion AUD	0.0%
2016 FY	1.52 Billion AUD	188.46%
2016 Q2	601.21 Million AUD	0.0%
2015 FY	528.94 Million AUD	98.99%
2015 Q2	319.94 Million AUD	0.0%
2015 Q4	528.94 Million AUD	0.0%
2014 Q2	256.62 Million AUD	0.0%
2014 Q4	265.82 Million AUD	0.0%
2014 FY	265.82 Million AUD	13.89%
2013 Q4	233.39 Million AUD	0.0%
2013 Q2	189.66 Million AUD	0.0%
2013 FY	233.39 Million AUD	332.74%
2013 Q3	233.39 Million AUD	23.05%
2012 FY	53.93 Million AUD	0.48%
2012 Q4	53.93 Million AUD	0.0%
2011 Q4	53.67 Million AUD	0.0%
2011 FY	53.67 Million AUD	-24.56%
2010 Q4	71.14 Million AUD	0.0%
2010 FY	71.14 Million AUD	785.41%
2009 Q4	8.03 Million AUD	0.0%
2009 FY	8.03 Million AUD	-31.28%
2008 FY	11.69 Million AUD	-24.61%
2008 Q4	11.69 Million AUD	0.0%
2007 Q4	15.51 Million AUD	0.0%
2007 FY	15.51 Million AUD	0.0%

Peer Total Assets Comparison of Mayne Pharma Group Limited

Name	Total Assets	Total Assets Difference
Firebrick Pharma Limited	2.4 Million AUD	-47406.858%